期刊文献+

微移植临床应用及治疗机制的研究进展 被引量:3

原文传递
导出
摘要 白血病的发病率在血液系统肿瘤中排第一位,我国白血病发病率呈逐年上升趋势。随着社会人口快速老龄化,老年急性白血病患者逐年增多。虽然国内外研究者采用了包括改良化学治疗方案、减低剂量预处理造血干细胞移植、免疫治疗等多种治疗手段,但因老年患者对化学治疗的耐受性差,对传统化学治疗方案反应不良,完全缓解(CR)率低,因此治疗相关的死亡率较高,长期无病存活率仍较低。近年来,微移植治疗技术为急性髓系白血病(AML)和骨髓增生异常综合征(MDS)患者,尤其是给老年患者提供了一种安全、有效的治疗方法。
作者 王利 王红祥
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2018年第4期248-251,共4页 Chinese Journal of Organ Transplantation
  • 相关文献

参考文献3

二级参考文献42

  • 1Alousi A,de Lima M.Reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation.Clin Adv Hematol Oncol,2007,5(7):560-570. 被引量:1
  • 2Kolb HJ,Mittermüller J,Clemm C,et al.Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients.Blood,1990,76(12):2462-2465. 被引量:1
  • 3Sykes M,Szot GL,Swenson KA,et al.Induction of high levels of allogeneic hematopoietic reconstitution and donorspecific tolerance without myelosuppressive conditioning.Nat Med,1997,3(7):783-787. 被引量:1
  • 4Storb R,Yu C,WagnerJL,et al.Stable mixed hematopoietic chimerism in DLA-identical litterrnate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.Blood,1997,89(8):3048-3054. 被引量:1
  • 5Niederwieser D,Lange T,Cross M,et al.Reduced intensity conditioning haematopoietic cell transplants in elderly patients with AML.Best Practice and Research Clinical Haematology,2006,19(4):825-838. 被引量:1
  • 6Baron F,Storb R.Hematopoietic cell transplantation after reduced-intensity conditioning for older adults with acute myeloid leukemia in complete remission.Curr Opin Hematol,2007,14(2):145-151. 被引量:1
  • 7Champlin R,Khouri I,Anderlini P,et al.Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation.Bone Marrow Transplant,2001,27(suppl 2):S13-S22. 被引量:1
  • 8Hegenbart U,Niederwieser D,Sandmaier BM,et al.Treatment for acute myelogenous leukemia by low-dose,totalbody,irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors.J Clin Oncol,2006,24(3):444-453. 被引量:1
  • 9de Lima M,Anagnostopoulos A,Munsell M,et al.Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome:dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation.Blood,2004,104(3):865-872. 被引量:1
  • 10van Besien K,Artz A,Smith S,et al.Fludarabine,melphalan,and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome.J Clin Oncol,2005,23(24):5728-5738. 被引量:1

共引文献18

同被引文献5

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部